Kimia Biosciences Ltd. (KIMIABL)
Market Closed
11 Aug, 22:00
MSE MSE Primary ₹
28. 99
+0.41
+1.4346%
₹
1.35B Market Cap
- P/E Ratio
- Div Yield
35 Volume
0 Eps
₹ 28.58
Previous Close Want to track KIMIABL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
KIMIABL closed today higher at ₹28.99, an increase of 1.4346% from yesterday's close, completing a monthly decrease of -9.6322% or -₹3.09. Over the past 12 months, KIMIABL stock lost -12.1515%.
KIMIABL is not paying dividends to its shareholders.
The last earnings report, released on May 25, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.4549%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.
KIMIABL Chart
People also search for
Kimia Biosciences Ltd. (KIMIABL) FAQ
What is the stock price today?
The current price is ₹28.99.
On which exchange is it traded?
Kimia Biosciences Ltd. is listed on MSE.
What is its stock symbol?
The ticker symbol is KIMIABL.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 1.35B.
Has Kimia Biosciences Ltd. ever had a stock split?
No, there has never been a stock split.
Kimia Biosciences Ltd. Profile
| Biotechnology Industry | Healthcare Sector | Mr. Sameer Goel CEO | MSE Exchange | INE285U01025 ISIN |
| India Country | 250 Employees | 15 Mar 2022 Last Dividend | - Last Split | - IPO Date |
Kimia Biosciences Ltd. is a pharmaceutical company that plays a significant role in the healthcare sector by focusing on manufacturing and marketing a wide range of active pharmaceutical ingredients (APIs) and intermediates. Its primary function is to supply high-quality, cost-effective drugs that contribute to the production of formulations crucial for treating various ailments. Kimia Biosciences Ltd. operates within the dynamic pharmaceutical industry, where it impacts numerous therapeutic areas by providing crucial components for drugs that address chronic and acute medical conditions. It serves both domestic and international markets, highlighting its importance in the global supply chain of pharmaceutical products. As the demand for diverse medical solutions continues to grow, companies like Kimia Biosciences Ltd. remain pivotal in addressing the need for accessible healthcare through their focus on research, development, and large-scale production capabilities.
Contact Information
Address: 974, Aggarwal Millennium Tower II
Phone: 91 11 4706 3600
Website: https://www.kimiabiosciences.com
